1. Home
  2. CELU vs VHC Comparison

CELU vs VHC Comparison

Compare CELU & VHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • VHC
  • Stock Information
  • Founded
  • CELU 2016
  • VHC 2005
  • Country
  • CELU United States
  • VHC United States
  • Employees
  • CELU N/A
  • VHC N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • VHC Multi-Sector Companies
  • Sector
  • CELU Health Care
  • VHC Miscellaneous
  • Exchange
  • CELU Nasdaq
  • VHC Nasdaq
  • Market Cap
  • CELU 64.3M
  • VHC 74.7M
  • IPO Year
  • CELU N/A
  • VHC 1999
  • Fundamental
  • Price
  • CELU $2.15
  • VHC $16.02
  • Analyst Decision
  • CELU Strong Buy
  • VHC
  • Analyst Count
  • CELU 1
  • VHC 0
  • Target Price
  • CELU $6.00
  • VHC N/A
  • AVG Volume (30 Days)
  • CELU 136.2K
  • VHC 9.9K
  • Earning Date
  • CELU 08-29-2025
  • VHC 11-12-2025
  • Dividend Yield
  • CELU N/A
  • VHC N/A
  • EPS Growth
  • CELU N/A
  • VHC N/A
  • EPS
  • CELU N/A
  • VHC N/A
  • Revenue
  • CELU $44,590,000.00
  • VHC $50,000.00
  • Revenue This Year
  • CELU N/A
  • VHC N/A
  • Revenue Next Year
  • CELU $76.00
  • VHC N/A
  • P/E Ratio
  • CELU N/A
  • VHC N/A
  • Revenue Growth
  • CELU 4.45
  • VHC 733.33
  • 52 Week Low
  • CELU $1.00
  • VHC $3.68
  • 52 Week High
  • CELU $5.22
  • VHC $21.53
  • Technical
  • Relative Strength Index (RSI)
  • CELU 34.61
  • VHC 50.60
  • Support Level
  • CELU $2.05
  • VHC $17.41
  • Resistance Level
  • CELU $2.41
  • VHC $18.79
  • Average True Range (ATR)
  • CELU 0.30
  • VHC 1.40
  • MACD
  • CELU -0.10
  • VHC -0.00
  • Stochastic Oscillator
  • CELU 6.57
  • VHC 42.48

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

About VHC VirnetX Holding Corp

VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. The company's software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services and critical infrastructures.

Share on Social Networks: